MDx Firm Atossa Genetics Raises $6.6M

The molecular diagnostics firm focused on breast cancer will use proceeds to launch its MASCT platform and establish commercial manufacturing of the system.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories